Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 54, Issue 10, Pages 1147-1158
Publisher
Wiley
Online
2014-05-27
DOI
10.1002/mc.22185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
- (2013) Ganji Purnachandra Nagaraju et al. ANGIOGENESIS
- A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
- (2013) Jonathan W Goldman et al. BMC CANCER
- Genetic Polymorphisms of Matrix Metalloproteinases and Clinical Outcomes in Colorectal Cancer Patients
- (2013) Wen-Chien Ting et al. International Journal of Medical Sciences
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- mTOR Signaling in Cancer Cell Motility and Tumor Metastasis
- (2012) Hongyu Zhou et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
- (2012) David A. Proia et al. INVESTIGATIONAL NEW DRUGS
- Expression of MMP2 and MMP9 (Gelatinases A and B) in Human Colon Cancer Cells
- (2011) Umadevi Damodharan et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- EMT: A new vision of hypoxia promoting cancer progression
- (2011) Jian Jiang et al. CANCER BIOLOGY & THERAPY
- Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
- (2011) W. Ying et al. MOLECULAR CANCER THERAPEUTICS
- Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells
- (2011) Suboj Babykutty et al. MOLECULAR CARCINOGENESIS
- Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients
- (2010) Anne Fog Lomholt et al. ACTA ONCOLOGICA
- NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
- (2010) Soly Wang et al. Cellular & Molecular Immunology
- Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
- (2010) Kyung Sook Park et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2
- (2009) Ponnuraj Nagendraprabhu et al. INVESTIGATIONAL NEW DRUGS
- Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells
- (2008) Stefania Cannito et al. CARCINOGENESIS
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors
- (2008) Tzu-Yin Lin et al. EXPERIMENTAL HEMATOLOGY
- NF-κB and epithelial to mesenchymal transition of cancer
- (2008) Chengyin Min et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
- (2008) L Liu et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now